Unlocking GLP-1 Potential by Targeting Secondary Mechanisms for Sustainable Weight Loss and Health
Time: 10:00 am
day: Day One
Details:
- Targeting the PI3K/AKT pathway to leverage a novel mechanism to modulate insulin signaling to overcome GLP-1 resistance for more durable metabolic health
- Combining GLP-1 agonists with lipid signaling modulators to engage multiple metabolic pathways simultaneously, resulting in greater weight loss and improved glycemic control than with GLP-1 monotherapy
- Focusing on receptor cross-talk as a mechanistic strategy to optimize the downstream effects of GLP-1 activation to enhance the therapeutic response and improve patient outcomes by addressing underlying limitations
Speakers:
